[{'address1': '450 Swan Street', 'city': 'Richmond', 'state': 'VIC', 'zip': '3121', 'country': 'Australia', 'phone': '61 3 9429 8800', 'fax': '61 3 9429 9455', 'website': 'https://www.promed.com.au', 'industry': 'Health Information Services', 'industryKey': 'health-information-services', 'industryDisp': 'Health Information Services', 'sector': 'Healthcare', 'sectorKey': 'healthcare', 'sectorDisp': 'Healthcare', 'longBusinessSummary': 'Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software. It also provides Visage RIS, a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; Promedicus.net, an e-health platform for secure email and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company was incorporated in 1983 and is headquartered in Richmond, Australia.', 'companyOfficers': [{'maxAge': 1, 'name': 'Dr. Sam Aaron Hupert M.B.B.S., M.D.', 'title': 'Co-Founder, CEO, MD & Executive Director', 'fiscalYear': 2024, 'totalPay': 965221, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Anthony Barry Hall B.Sc., B.Sc.(Hons), M.Sc.', 'title': 'Co-Founder, Technology Director & Executive Director', 'fiscalYear': 2024, 'totalPay': 373261, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Clayton James Hatch B.Comm, CPA, CPA', 'title': 'Chief Financial Officer', 'fiscalYear': 2024, 'totalPay': 387931, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Malte  Westerhoff', 'title': 'GM of Europe & Global CTO', 'fiscalYear': 2024, 'totalPay': 1249279, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Brad  Levin', 'title': 'GM of North America & Global Head of Marketing', 'fiscalYear': 2024, 'totalPay': 393976, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Sharni L. Redenbach', 'title': 'People & Culture Director', 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Sean  Lambright', 'title': 'Global Head of Sales - Visage Imaging Inc', 'fiscalYear': 2024, 'totalPay': 1206558, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Teresa  Gschwind', 'title': 'Global Head of Customer Service of Visage Imaging Inc.', 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Danny  English C.A.', 'title': 'Financial Controller & Company Secretary', 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}], 'auditRisk': 1, 'boardRisk': 6, 'compensationRisk': 6, 'shareHolderRightsRisk': 1, 'overallRisk': 4, 'governanceEpochDate': 1725148800, 'compensationAsOfEpochDate': 1735603200, 'maxAge': 86400, 'priceHint': 2, 'previousClose': 156.98, 'open': 160.2, 'dayLow': 158.975, 'dayHigh': 163.79, 'regularMarketPreviousClose': 156.98, 'regularMarketOpen': 160.2, 'regularMarketDayLow': 158.975, 'regularMarketDayHigh': 163.79, 'dividendRate': 0.44, 'dividendYield': 0.0028, 'exDividendDate': 1725408000, 'payoutRatio': 0.4425, 'fiveYearAvgDividendYield': 0.34, 'beta': 0.557, 'trailingPE': 209.98718, 'forwardPE': 163.79, 'volume': 117064, 'regularMarketVolume': 117064, 'averageVolume': 291273, 'averageVolume10days': 211548, 'averageDailyVolume10Day': 211548, 'bid': 163.67, 'ask': 163.72, 'marketCap': 17115890688, 'fiftyTwoWeekLow': 70.67, 'fiftyTwoWeekHigh': 163.79, 'priceToSalesTrailing12Months': 105.980095, 'fiftyDayAverage': 140.627, 'twoHundredDayAverage': 115.4587, 'trailingAnnualDividendRate': 0.4, 'trailingAnnualDividendYield': 0.0025480953, 'currency': 'AUD', 'enterpriseValue': 16239261696, 'profitMargins': 0.51265, 'floatShares': 50924882, 'sharesOutstanding': 104499000, 'heldPercentInsiders': 0.51233, 'heldPercentInstitutions': 0.13763, 'impliedSharesOutstanding': 104499000, 'bookValue': 1.798, 'priceToBook': 91.09566, 'lastFiscalYearEnd': 1719705600, 'nextFiscalYearEnd': 1751241600, 'mostRecentQuarter': 1719705600, 'earningsQuarterlyGrowth': 0.391, 'netIncomeToCommon': 82794000, 'trailingEps': 0.78, 'forwardEps': 1.0, 'pegRatio': 5.31, 'enterpriseToRevenue': 100.552, 'enterpriseToEbitda': 143.639, '52WeekChange': 1.1769519, 'SandP52WeekChange': 0.23285389, 'lastDividendValue': 0.22, 'lastDividendDate': 1725408000, 'exchange': 'ASX', 'quoteType': 'EQUITY', 'symbol': 'PME.AX', 'underlyingSymbol': 'PME.AX', 'shortName': 'PROMEDICUS FPO [PME]', 'longName': 'Pro Medicus Limited', 'firstTradeDateEpochUtc': 971046000, 'timeZoneFullName': 'Australia/Sydney', 'timeZoneShortName': 'AEST', 'uuid': 'ce901cc0-ae71-340a-89b2-65d7da3af994', 'messageBoardId': 'finmb_7653087', 'gmtOffSetMilliseconds': 36000000, 'currentPrice': 163.79, 'targetHighPrice': 152.68, 'targetLowPrice': 57.86, 'targetMeanPrice': 111.66, 'targetMedianPrice': 120.0, 'recommendationMean': 2.7, 'recommendationKey': 'hold', 'numberOfAnalystOpinions': 13, 'totalCash': 155424992, 'totalCashPerShare': 1.488, 'ebitda': 113056000, 'totalDebt': 2069000, 'quickRatio': 5.895, 'currentRatio': 5.977, 'totalRevenue': 161500992, 'debtToEquity': 1.102, 'revenuePerShare': 1.546, 'returnOnAssets': 0.30677998, 'returnOnEquity': 0.50715, 'freeCashflow': 69200496, 'operatingCashflow': 81979000, 'earningsGrowth': 0.389, 'revenueGrowth': 0.285, 'grossMargins': 0.99814004, 'ebitdaMargins': 0.70002997, 'operatingMargins': 0.73069, 'financialCurrency': 'AUD', 'trailingPegRatio': None}]